An overview of the pharmacokinetics and pharmacodynamics of amlodipine in elderly persons with systemic hypertension.
Pharmacokinetic and pharmacodynamic data were compared between elderly and young patients with hypertension who received single intravenous doses of amlodipine, a dihydropyridine calcium antagonist, followed by oral administration of amlodipine up to 10 mg once daily for 12 weeks. After intravenous administration, elderly patients had prolonged elimination half-life values (58 +/- 11 vs 42 +/- 8 hr; p < 0.05) caused by decreased clearance (19 +/- 5 vs 7 liters/hr; p < 0.05). Systolic and diastolic blood pressures were significantly decreased from baseline throughout the 3-month treatment period in both groups. After long-term oral administration, elderly and young patients had comparable decreases in mean blood pressure at a given drug plasma concentration. The antihypertensive effect of amlodipine is well correlated with plasma concentration and, at a given concentration, is similar in both elderly and young patients.
Abernethy
D R
DR
Brown University, Department of Medicine, Rhode Island Hospital, Providence 02903.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D017311:Amlodipine / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology*; D009320:Atrial Natriuretic Factor / Q000097:blood; D001682:Biological Availability; D001794:Blood Pressure / Q000187:drug effects; D015924:Blood Pressure Monitors; D004334:Drug Administration Schedule; D006207:Half-Life; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D012083:Renin / Q000097:blood
D017311:Amlodipine; D009320:Atrial Natriuretic Factor; D012083:Renin